WAVEMAN · COMPANY

POCI · Precision Optics Corporation, Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

POCI

Name: PRECISION OPTICS CORPORATION, INC. (POCI) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

PRECISION OPTICS CORPORATION, INC.

MEDICAL DEVICES · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · CIK 0000867840

CLUSTER · 3 INSIDERSC-SUITE BUYING · 3☆ WATCH

INSIDER NET · 180D

$230.0K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-0.1%

XBRL, annual

NET MARGIN

-30.3%

CONVERSIONS · 180D

codes C/M, not in net · $28.8K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$230.0K over 180 days

more than 85% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

19 funds added or opened last quarter

below 75% of Medical Devices

REVENUE

-0.1% year over year

below 74% of Medical Devices

MARGIN

-30.3% net margin

below 65% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

3 insiders independently bought a net $230.0K — no planned sales are queued against it.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -5.8%

-5.8%12M

INSIDER BUY

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

3 insiders reported buying shares.

The record shows a net $230.0K bought by insiders over 180 days, 19 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, PRECISION OPTICS CORPORATION, INC. insiders bought a net $230.0K of stock across 5 Form 4 purchases and sales, with 3 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

COLL WAYNE M

Chief Financial Officer

BUY

2026-03-30

20,833.0

$75.0K

TRAUT JOSEPH

Chief Operating Officer

BUY

2026-03-30

41,666.0

$150.0K

Forkey Joseph Norman

Chief Executive Officer

BUY

2026-03-30

1,388.0

$5.0K

Anania Peter V.

Director

SELL

2024-11-20

14,400.0

$72.0K

Anania Peter V.

Director

BUY

2022-11-30

332.0

$2.0K

5 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

NEEDHAM INVESTMENT MANAGEMENT LLC

1,670,550.0 sh

$8.5M

Nantahala Capital Management, LLC

560,000.0 sh

$2.9M

MYDA Advisors LLC

375,000.0 sh

$1.9M

VANGUARD CAPITAL MANAGEMENT LLC

325,751.0 sh

$1.7M

WealthTrust Axiom LLC

260,458.0 sh

$1.3M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Needham Aggressive Growth Fund

$7.3M POSITION · AS OF 2026-03-31

0.5%

iShares Micro-Cap ETF

$66.5K POSITION · AS OF 2026-03-31

0.0%

1290 VT Micro Cap Portfolio

$4.6K POSITION · AS OF 2026-03-31

0.0%

Fidelity Extended Market Index Fund

$126.1K POSITION · AS OF 2026-02-28

0.0%

VANGUARD EXTENDED MARKET INDEX FUND

$237.8K POSITION · AS OF 2026-03-31

0.0%

Fidelity Total Market Index Fund

$52.3K POSITION · AS OF 2026-02-28

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Executive pay vs shareholder return · Dr. Joseph Forkey

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2024

$1.1M

$1.0M

$288.6K

-8%

—

2023

$251.0K

$284.6K

+9%

—

2022

$240.4K

$209.5K

+16%

—

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-06	2024-06	2023-06	2022-06
REVENUE	$19.1M	$19.1M	$21.0M	$15.7M
GROSS PROFIT	$3.4M	$5.8M	$7.7M	$4.9M
OPERATING INCOME	$-5.6M	$-2.7M	$-638.5K	$-1.5M
NET INCOME	$-5.8M	$-3.0M	$-144.6K	$-928.4K
EPS (DILUTED)	-0.85	-0.49	-0.03	-0.18
OPERATING CASH FLOW	$-3.5M	$-2.7M	$-81.1K	$-933.4K
CASH	$1.8M	$405.3K	$2.9M	$605.7K
LONG-TERM DEBT	$1.3M	$1.9M	$2.2M	$2.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE